Shince

Shince is a biotechnology company specializing in DNA-encoded library (DEL) technology to accelerate the discovery of novel small molecule therapeutics. Headquartered in Suzhou, China, the company provides a high-throughput screening platform that allows for the rapid evaluation of billions of chemical compounds against diverse biological targets. Shince offers end-to-end services, including custom library construction, selection, and medicinal chemistry support to optimize hits into lead candidates. By leveraging its proprietary DEL platform, Shince partners with global pharmaceutical and biotech firms to address unmet medical needs in oncology, immunology, and metabolic disorders. The company's technology significantly streamlines the hit-to-lead process, providing a cost-effective alternative to traditional high-throughput screening.